[
  {
    "ts": "2026-01-05T03:10:13+00:00",
    "headline": "Taking Another Look at Amgen (AMGN)’s Valuation After Its Recent Share Price Pullback",
    "summary": "Amgen (AMGN) has been quietly grinding higher over the past year, and that steady move is catching more investor attention. With revenue and earnings both growing, the stock’s recent pullback looks worth a closer look. See our latest analysis for Amgen. At around $327.64, Amgen’s modest recent share price pullback comes after a strong 90 day share price return of 11.4 percent and a one year total shareholder return of 29.5 percent, which suggests momentum is still broadly constructive. If...",
    "url": "https://finance.yahoo.com/news/taking-another-look-amgen-amgn-031013515.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ec3c930e-e061-31bd-b8aa-12f4deded9b6",
      "content": {
        "id": "ec3c930e-e061-31bd-b8aa-12f4deded9b6",
        "contentType": "STORY",
        "title": "Taking Another Look at Amgen (AMGN)’s Valuation After Its Recent Share Price Pullback",
        "description": "",
        "summary": "Amgen (AMGN) has been quietly grinding higher over the past year, and that steady move is catching more investor attention. With revenue and earnings both growing, the stock’s recent pullback looks worth a closer look. See our latest analysis for Amgen. At around $327.64, Amgen’s modest recent share price pullback comes after a strong 90 day share price return of 11.4 percent and a one year total shareholder return of 29.5 percent, which suggests momentum is still broadly constructive. If...",
        "pubDate": "2026-01-05T03:10:13Z",
        "displayTime": "2026-01-05T03:10:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/taking-another-look-amgen-amgn-031013515.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/taking-another-look-amgen-amgn-031013515.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]